1. Home
  2. ALKS vs BCO Comparison

ALKS vs BCO Comparison

Compare ALKS & BCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • BCO
  • Stock Information
  • Founded
  • ALKS 1987
  • BCO 1859
  • Country
  • ALKS Ireland
  • BCO United States
  • Employees
  • ALKS N/A
  • BCO N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • BCO Oil Refining/Marketing
  • Sector
  • ALKS Health Care
  • BCO Consumer Discretionary
  • Exchange
  • ALKS Nasdaq
  • BCO Nasdaq
  • Market Cap
  • ALKS 4.9B
  • BCO 4.2B
  • IPO Year
  • ALKS 1991
  • BCO N/A
  • Fundamental
  • Price
  • ALKS $27.87
  • BCO $114.98
  • Analyst Decision
  • ALKS Strong Buy
  • BCO Strong Buy
  • Analyst Count
  • ALKS 14
  • BCO 1
  • Target Price
  • ALKS $41.29
  • BCO $138.00
  • AVG Volume (30 Days)
  • ALKS 1.9M
  • BCO 265.9K
  • Earning Date
  • ALKS 10-23-2025
  • BCO 11-05-2025
  • Dividend Yield
  • ALKS N/A
  • BCO 0.87%
  • EPS Growth
  • ALKS 21.99
  • BCO 24.94
  • EPS
  • ALKS 2.08
  • BCO 3.72
  • Revenue
  • ALKS $1,505,296,000.00
  • BCO $5,069,900,000.00
  • Revenue This Year
  • ALKS N/A
  • BCO $5.33
  • Revenue Next Year
  • ALKS $1.66
  • BCO $4.60
  • P/E Ratio
  • ALKS $13.19
  • BCO $31.71
  • Revenue Growth
  • ALKS N/A
  • BCO 2.17
  • 52 Week Low
  • ALKS $25.17
  • BCO $80.10
  • 52 Week High
  • ALKS $36.45
  • BCO $117.99
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 48.33
  • BCO 64.40
  • Support Level
  • ALKS $26.40
  • BCO $113.95
  • Resistance Level
  • ALKS $28.65
  • BCO $117.65
  • Average True Range (ATR)
  • ALKS 1.13
  • BCO 2.22
  • MACD
  • ALKS -0.20
  • BCO -0.57
  • Stochastic Oscillator
  • ALKS 41.41
  • BCO 59.05

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About BCO Brinks Company (The)

The Brink's Co is a provider of secure logistics and security solutions for cash and other valuables. Its segments include: North America segment includes operations in the U.S. and Canada, including the Brink's Global Services (BGS) line of business; Latin America segment consists operations in Latin American countries where it has an ownership interest, including the BGS line of business; Europe segment includes total operations in European countries that provide services outside of the BGS line of business; and Rest of World segment consists operations in the Middle East, Africa and Asia. It also includes total operations in European countries that provides BGS services and BGS activity in Latin American countries. It derives maximum revenue from North America segment.

Share on Social Networks: